Locally advanced NSCLC: a plea for sparing the ipsilateral normal lung—prospective, clinical trial with DART-bid (dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily) by VMAT

Autor: Karl Wurstbauer, Margit Kazil, Marco Meinschad, Raoul Pinter, Catharina De Vries, Patrick Clemens, Christof Kreuter, Tamara Hernler, Wolfgang Hitzl, Peter Cerkl, Thomas Künzler, Alexander De Vries

Publikováno v: Radiation Oncology, Vol 17, Iss 1, Pp 1-10 (2022)

Abstract Background In radiation treatment of locally advanced non-small cell lung cancer (LA-NSCLC), ‘margins’ from internal target volumes to planning target volumes in the range of 12 to 23 mm are reported, and avoiding exposure of the contral

Externí odkaz: https://doaj.org/article/1daf369b7dd44f4c8d2ad05912651f12

DART-bid for loco-regionally advanced NSCLC : Summary of acute and late toxicity with long-term follow-up; experiences with pulmonary dose constraints.

Autor: Wurstbauer K; Institute for research and development on Advanced Radiation Technologies (radART), Paracelsus Medical University, Müllner Hauptstraße 48, 5020, Salzburg, Austria. k.wurstbauer@salk.at., Zehentmayr F; Institute for research and development on Advanced Radiation Technologies (radART), Paracelsus Medical University, Müllner Hauptstraße 48, 5020, Salzburg, Austria.; Department of Radiotherapy and Radiation Oncology , Landeskrankenhaus, Paracelsus Medical University Clinics, Salzburg, Austria., Deutschmann H; Institute for research and development on Advanced Radiation Technologies (radART), Paracelsus Medical University, Müllner Hauptstraße 48, 5020, Salzburg, Austria.; Department of Radiotherapy and Radiation Oncology , Landeskrankenhaus, Paracelsus Medical University Clinics, Salzburg, Austria., Dagn K; Department of Radiotherapy and Radiation Oncology , Landeskrankenhaus, Paracelsus Medical University Clinics, Salzburg, Austria., Exeli AK; Department of Radiotherapy and Radiation Oncology , Landeskrankenhaus, Paracelsus Medical University Clinics, Salzburg, Austria., Kopp P; Department of Radiotherapy and Radiation Oncology , Landeskrankenhaus, Paracelsus Medical University Clinics, Salzburg, Austria., Porsch P; Departement of Pneumology, Paracelsus Medical University Clinics, Salzburg, Austria., Maurer B; Departement of Pneumology, Paracelsus Medical University Clinics, Salzburg, Austria., Studnicka M; Departement of Pneumology, Paracelsus Medical University Clinics, Salzburg, Austria., Sedlmayer F; Institute for research and development on Advanced Radiation Technologies (radART), Paracelsus Medical University, Müllner Hauptstraße 48, 5020, Salzburg, Austria.; Department of Radiotherapy and Radiation Oncology , Landeskrankenhaus, Paracelsus Medical University Clinics, Salzburg, Austria.

Publikováno v: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] [Strahlenther Onkol] 2017 Apr; Vol. 193 (4), pp. 315-323. Date of Electronic Publication: 2017 Jan 23.

DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)-a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume.

Autor: Wurstbauer, Karl^1,2, Deutschmann, Heinz¹, Dagn, Karin¹, Kopp, Peter¹, Zehentmayr, Franz¹, Lamprecht, Bernd³, Porsch, Peter³, Wegleitner, Birgit³, Studnicka, Michael³, Sedlmayer, Felix¹

Publikováno v: Radiation Oncology. 2013, Vol. 8 Issue 1, p1-10. 10p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)–a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume

Autor: P. Porsch, Felix Sedlmayer, Franz Zehentmayr, Heinz Deutschmann, Birgit Wegleitner, Bernd Lamprecht, Michael Studnicka, K. Dagn, Peter Kopp, Karl Wurstbauer

Publikováno v: Radiation Oncology (London, England)

Background Sequential chemo-radiotherapies with intensive radiation components deliver promising results in non-resected non-small cell lung cancer (NSCLC). In general, radiation doses are determined by dose constraints for normal tissues, not by fea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e194b7f7508e701146cedb9d1412ea6
https://doi.org/10.1186/1748-717x-8-49